TRENDS IN THE USE OF SECOND-GENERATION ANDROGEN RECEPTOR AXIS INHIBITORS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER AND CLINICAL FACTORS PREDICTING BIOLOGICAL RECURRENCE

被引：0
|
作者：
Nakane, Keita
Watanabe, Hiromitsu
Naiki, Taku
Takahara, Kiyoshi
Yasui, Takahiro
Miyake, Hideaki
Shiroki, Ryoichi
Koie, Takuya
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP60-09
引用
收藏
页码：E1002 / E1003
页数：2
相关论文
共 50 条
  • [31] Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors
    Wefel, Jeffrey S.
    Ryan, Charles J.
    Van, Julie
    Jackson, James C.
    Morgans, Alicia K.
    CNS DRUGS, 2022, 36 (05) : 419 - 449
  • [32] Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors
    Jeffrey S. Wefel
    Charles J. Ryan
    Julie Van
    James C. Jackson
    Alicia K. Morgans
    CNS Drugs, 2022, 36 : 419 - 449
  • [33] Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy
    Li, Heng
    Zhang, Yucong
    Li, Dong
    Ma, Xin
    Xu, Kai
    Ding, Beichen
    Li, Hongzhao
    Wang, Zhize
    Ouyang, Wei
    Long, Gongwei
    Zeng, Jin
    Liu, Haoran
    Yan, Libin
    Zhang, Yangjun
    Liu, Zheng
    Guan, Wei
    Hu, Zhiquan
    Liu, Cong
    Wan, Jie
    Wang, Guoping
    Pu, Xiaoyong
    Zhang, Minghui
    Guo, Linlang
    An, Ruihua
    Qi, Jiping
    Guo, Aitao
    Ye, Zhangqun
    Liu, Jiumin
    Zhang, Xu
    Xu, Hua
    EUROPEAN UROLOGY, 2021, 79 (06) : 879 - 886
  • [34] Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy
    Afferi, Luca
    Longoni, Mattia
    Moschini, Marco
    Gandaglia, Giorgio
    Morgans, Alicia K.
    Cathomas, Richard
    Mattei, Agostino
    Breda, Alberto
    Scarpa, Roberto Mario
    Papalia, Rocco
    de Nunzio, Cosimo
    Esperto, Francesco
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 173 - 182
  • [35] EXPLORING THE DUAL IMPACT TO TREATMENT OUTCOMES IN PATIENTS WITH SHORT TIME TO NADIR PSA UNDER ANDROGEN RECEPTOR PATHWAY INHIBITORS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER
    Shih, Hsin-Yo
    Tseng, Chi-Shin
    Hong, Jian-Hua
    Chueh, Jeff S.
    Huang, Chao-Yuan
    JOURNAL OF UROLOGY, 2024, 211 (05): : E224 - E225
  • [36] Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy
    Luca Afferi
    Mattia Longoni
    Marco Moschini
    Giorgio Gandaglia
    Alicia K. Morgans
    Richard Cathomas
    Agostino Mattei
    Alberto Breda
    Roberto Mario Scarpa
    Rocco Papalia
    Cosimo de Nunzio
    Francesco Esperto
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 173 - 182
  • [37] Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer
    Sato, Hiromi
    Narita, Shintaro
    Tsuchiya, Norihiko
    Koizumi, Atsushi
    Nara, Taketoshi
    Kanda, Sohei
    Numakura, Kazuyuki
    Tsuruta, Hiroshi
    Maeno, Atsushi
    Saito, Mitsuru
    Inoue, Takamitsu
    Satoh, Shigeru
    Nomura, Kyoko
    Habuchi, Tomonori
    BMC UROLOGY, 2018, 18
  • [38] Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review
    Raval, Amit D.
    Chen, Stephanie
    Littleton, Natasha
    Constantinovici, Niculae
    Goebell, Peter J.
    BJU INTERNATIONAL, 2025, 135 (03) : 408 - 421
  • [39] Addition of androgen receptor targeted agents to androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
    Maiorano, B. A.
    De Giorgi, U.
    Roviello, G.
    Messina, C.
    Altavilla, A.
    Cattrini, C.
    Mennitto, A.
    Maiello, E.
    Di Maio, M.
    ESMO OPEN, 2022, 7 (05)
  • [40] Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer
    Hiromi Sato
    Shintaro Narita
    Norihiko Tsuchiya
    Atsushi Koizumi
    Taketoshi Nara
    Sohei Kanda
    Kazuyuki Numakura
    Hiroshi Tsuruta
    Atsushi Maeno
    Mitsuru Saito
    Takamitsu Inoue
    Shigeru Satoh
    Kyoko Nomura
    Tomonori Habuchi
    BMC Urology, 18
12345